RADL3 Stock Overview
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for RADL3 from our risk checks.
Raia Drogasil S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$26.17 |
| 52 Week High | R$30.15 |
| 52 Week Low | R$24.30 |
| Beta | 0.33 |
| 1 Month Change | -0.80% |
| 3 Month Change | 2.91% |
| 1 Year Change | -2.62% |
| 3 Year Change | 5.17% |
| 5 Year Change | 113.40% |
| Change since IPO | 3,882.95% |
Recent News & Updates
Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08
Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Recent updates
Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Dec 12Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Nov 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled
Oct 27Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Sep 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Aug 19Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return
Jul 18Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Jun 03Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
May 13Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down
Apr 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Feb 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes
Jan 07Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Dec 07Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Nov 22Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital
Sep 08Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Aug 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Aug 09There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Jun 09With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting
May 25Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
May 10Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Feb 09Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Dec 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Nov 19These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Nov 04Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture
Sep 01Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Aug 17These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jul 28Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends
May 10We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt
Mar 10Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?
Feb 16
Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 29You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend
Jan 11Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?
Dec 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Dec 03Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Aug 25Should We Be Excited About The Trends Of Returns At Raia Drogasil (BVMF:RADL3)?
Aug 12What Kind Of Shareholders Hold The Majority In Raia Drogasil S.A.'s (BVMF:RADL3) Shares?
Aug 12What You Can Learn From Raia Drogasil S.A.'s (BVMF:RADL3) P/E
Jul 30Raia Drogasil (BVMF:RADL3) Is Growing Earnings But Are They A Good Guide?
Jul 17Is Raia Drogasil S.A.'s(BVMF:RADL3) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jul 04Shareholder Returns
| RADL3 | BR Consumer Retailing | BR Market | |
|---|---|---|---|
| 7D | -0.3% | 3.1% | -0.3% |
| 1Y | -2.6% | 0.9% | 10.8% |
Return vs Industry: RADL3 underperformed the BR Consumer Retailing industry which returned 0.9% over the past year.
Return vs Market: RADL3 underperformed the BR Market which returned 10.8% over the past year.
Price Volatility
| RADL3 volatility | |
|---|---|
| RADL3 Average Weekly Movement | 3.1% |
| Consumer Retailing Industry Average Movement | 5.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.0% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: RADL3 has not had significant price volatility in the past 3 months.
Volatility Over Time: RADL3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1905 | 57,708 | Marcílio Pousada | www.rd.com.br |
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A. Fundamentals Summary
| RADL3 fundamental statistics | |
|---|---|
| Market cap | R$44.88b |
| Earnings (TTM) | R$1.05b |
| Revenue (TTM) | R$35.14b |
42.7x
P/E Ratio1.3x
P/S RatioIs RADL3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RADL3 income statement (TTM) | |
|---|---|
| Revenue | R$35.14b |
| Cost of Revenue | R$24.60b |
| Gross Profit | R$10.54b |
| Other Expenses | R$9.49b |
| Earnings | R$1.05b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 06, 2024
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 30.01% |
| Net Profit Margin | 2.99% |
| Debt/Equity Ratio | 46.2% |
How did RADL3 perform over the long term?
See historical performance and comparison